Bulimia nervosa assessment

Wilson, G.T. and Smith D. (1989) Assessment of bulimia nervosa an evaluation of the eating disorders examination. Int/ Eat Disord 8 173-179. 

Mcgilley BM, Pryor TL. Assessment and treatment of bulimia nervosa. Am Fam Physician 1998 57 2743-2750. 

Powers PS. Initial assessment and early treatment options for anorexia nervosa and bulimia nervosa. Psychiatr CUn North Am 1996 19 639-655. 

Monoamine oxidase inhibitors, such as SSRIs, have been shown to be effective in the treatment of depression, and they have become among the most widely used prescription drugs in the United States. Prozac is used not only to treat major depressive disorders but also bulimia nervosa, obsessive-compulsive disorder, panic disorder, and premenstrual dysphoric disorder. Multiple serotonin receptor subtypes are involved. Specific serotonin receptor subtype agonists and antagonists have been radiolabeled with positron-emitting tracers to assess the state of the serotonergic system. 

These data suggest that both NPY and PYY may be sensitive to factors regulating body weight in humans. The evidence provided by these studies, however, is not conclusive of the involvement of NPY or PYY in the pathology of such eating disorders, and is regarded by many as a simplistic view of what are highly complex diseases. Further research is needed to assess the role of these peptides in bulimia and anorexia nervosa. 

---